PMID- 19277984 OWN - NLM STAT- MEDLINE DCOM- 20090514 LR - 20220408 IS - 1097-4652 (Electronic) IS - 0021-9541 (Linking) VI - 220 IP - 1 DP - 2009 Jul TI - Amyloid-beta up-regulates complement factor B in retinal pigment epithelial cells through cytokines released from recruited macrophages/microglia: Another mechanism of complement activation in age-related macular degeneration. PG - 119-28 LID - 10.1002/jcp.21742 [doi] AB - One of the earliest signs of age-related macular degeneration (AMD) is the formation of drusen which are extracellular deposits beneath the retinal pigmented epithelium (RPE). To investigate the relationship between drusen and AMD, we focused on amyloid beta (Abeta), a major component of drusen and also of senile plaques in the brain of Alzheimer's patients. We previously reported that Abeta was accumulated in drusen-like structure in senescent neprilysin gene-disrupted mice. The purpose of this study was to investigate the influence of Abeta on factor B, the main activator of the complement alternative pathway. The results showed that Abeta did not directly modulate factor B expression in RPE cells, but increased the production of monocyte chemoattractant protein-1 (MCP-1). Abeta also increased the production of IL-1beta and TNF-alpha in macrophages/microglia, and exposure of RPE cells to IL-1beta and TNF-alpha significantly up-regulated factor B. Co-cultures of RPE cells and macrophages/microglia in the presence of Abeta significantly increased the expression of factor B in RPE. These findings indicate that cytokines produced by macrophages/microglia that were recruited by MCP-1 produced in RPE cells stimulated by Abeta up-regulate factor B in RPE cells. Thus, a combined mechanism exists for Abeta-induced for the activation of the complement alternative pathway in the subretinal space; cytokine-induced up-regulation of activator factor B and dysfunction of the inhibitor factor I by direct binding to Abeta as suggested in our earlier study. FAU - Wang, Jiying AU - Wang J AD - Department of Ophthalmology and Visual Science, Tokyo Medical and Dental University, Tokyo, Japan. FAU - Ohno-Matsui, Kyoko AU - Ohno-Matsui K FAU - Yoshida, Takeshi AU - Yoshida T FAU - Shimada, Noriaki AU - Shimada N FAU - Ichinose, Shizuko AU - Ichinose S FAU - Sato, Tetsuji AU - Sato T FAU - Mochizuki, Manabu AU - Mochizuki M FAU - Morita, Ikuo AU - Morita I LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - United States TA - J Cell Physiol JT - Journal of cellular physiology JID - 0050222 RN - 0 (Amyloid beta-Peptides) RN - 0 (CCL2 protein, human) RN - 0 (Chemokine CCL2) RN - 0 (Cytokines) RN - 0 (Interleukin-1beta) RN - 0 (Peptide Fragments) RN - 0 (RNA, Messenger) RN - 0 (Tumor Necrosis Factor-alpha) RN - 0 (amyloid beta-protein (1-40)) RN - 82115-62-6 (Interferon-gamma) RN - EC 3.4.21.47 (Complement Factor B) RN - EC 3.4.24.11 (Neprilysin) SB - IM MH - Amyloid beta-Peptides/*metabolism MH - Animals MH - Autocrine Communication MH - Cells, Cultured MH - Chemokine CCL2/metabolism MH - Coculture Techniques MH - *Complement Activation MH - Complement Factor B/genetics/*metabolism MH - Cytokines/*metabolism MH - Epithelial Cells/*immunology MH - Humans MH - Interferon-gamma/metabolism MH - Interleukin-1beta/metabolism MH - Macrophages, Peritoneal/*immunology MH - Macular Degeneration/*immunology MH - Male MH - Mice MH - Mice, Inbred C57BL MH - Mice, Knockout MH - Microglia/*immunology MH - Neprilysin/deficiency/genetics MH - Paracrine Communication MH - Peptide Fragments/*metabolism MH - RNA, Messenger/metabolism MH - Retinal Drusen/immunology MH - Retinal Pigment Epithelium/*immunology MH - Tumor Necrosis Factor-alpha/metabolism MH - Up-Regulation EDAT- 2009/03/12 09:00 MHDA- 2009/05/15 09:00 CRDT- 2009/03/12 09:00 PHST- 2009/03/12 09:00 [entrez] PHST- 2009/03/12 09:00 [pubmed] PHST- 2009/05/15 09:00 [medline] AID - 10.1002/jcp.21742 [doi] PST - ppublish SO - J Cell Physiol. 2009 Jul;220(1):119-28. doi: 10.1002/jcp.21742.